agilon health (NYSE:AGL) Research Coverage Started at Needham & Company LLC

Needham & Company LLC began coverage on shares of agilon health (NYSE:AGL) in a research report report published on Friday, MarketBeat reports. The brokerage issued a hold rating on the stock.

Several other equities analysts also recently issued reports on the company. Stifel Nicolaus cut their target price on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research report on Tuesday, November 12th. Royal Bank of Canada reiterated an “outperform” rating and set a $3.00 price target on shares of agilon health in a research note on Tuesday, November 19th. Barclays reduced their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday, November 11th. JMP Securities lowered agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Finally, Citigroup cut their price target on shares of agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a report on Wednesday, November 13th. Two investment analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $3.98.

agilon health Price Performance

Shares of NYSE AGL opened at $2.42 on Friday. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $8.20. The company has a market cap of $997.08 million, a PE ratio of -2.57 and a beta of 0.53. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The business has a 50-day simple moving average of $2.07 and a two-hundred day simple moving average of $3.73.

agilon health (NYSE:AGL) last released its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The company had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same quarter last year, the business earned ($0.06) earnings per share. As a group, equities analysts expect that agilon health will post -0.52 EPS for the current fiscal year.

Insider Activity

In other news, Director John William Wulf acquired 45,000 shares of the stock in a transaction that occurred on Thursday, December 5th. The shares were bought at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. This represents a 27.93 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Karen Mcloughlin acquired 25,000 shares of the business’s stock in a transaction on Friday, December 13th. The shares were purchased at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the purchase, the director now owns 73,166 shares in the company, valued at $160,965.20. This represents a 51.90 % increase in their position. The disclosure for this purchase can be found here. Insiders acquired 90,000 shares of company stock worth $198,100 over the last three months. 3.20% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. State Street Corp raised its position in shares of agilon health by 3.0% in the third quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after buying an additional 215,733 shares during the last quarter. Geode Capital Management LLC grew its stake in agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after acquiring an additional 84,889 shares in the last quarter. Citigroup Inc. raised its holdings in agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after acquiring an additional 1,941,993 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after purchasing an additional 1,083,492 shares in the last quarter. Finally, AQR Capital Management LLC boosted its holdings in shares of agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.